ArticleFrontiers in pharmacology2022

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells.

Giada Lodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.